David T. Yang

5.4k total citations
91 papers, 2.7k citations indexed

About

David T. Yang is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, David T. Yang has authored 91 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pathology and Forensic Medicine, 28 papers in Oncology and 27 papers in Molecular Biology. Recurrent topics in David T. Yang's work include Lymphoma Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (18 papers) and Viral-associated cancers and disorders (10 papers). David T. Yang is often cited by papers focused on Lymphoma Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (18 papers) and Viral-associated cancers and disorders (10 papers). David T. Yang collaborates with scholars based in United States, Canada and China. David T. Yang's co-authors include Brad S. Kahl, Matthew J. Oberley, George M. Rodgers, Hyunhee Kim, Shigeki Miyamoto, Willa A. Hsueh, Jerry L. Nadler, T M Chan, S. D. Scott and Young Y. Jeng and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

David T. Yang

89 papers receiving 2.6k citations

Peers

Countries citing papers authored by David T. Yang

Since Specialization

Citations

This map shows the geographic impact of David T. Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David T. Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David T. Yang more than expected).

Fields of papers citing papers by David T. Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David T. Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David T. Yang. The network helps show where David T. Yang may publish in the future.

Co-authorship network of co-authors of David T. Yang

This figure shows the co-authorship network connecting the top 25 collaborators of David T. Yang. A scholar is included among the top collaborators of David T. Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David T. Yang. David T. Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice 2023 ·Journal of Clinical Investigation ·(unknown), (unknown), (unknown), Erik A. Ranheim, (unknown), Daniel R. Matson, (unknown), (unknown), Yun Zhou, Xin Gao, Kalyan Nadiminti, David T. Yang, Vu L. Tran, Eric Padron, Shigeki Miyamoto, Emery H. Bresnick, Jing Zhang	10
2	EGR1 Addiction in Diffuse Large B-cell Lymphoma 2021 ·Molecular Cancer Research ·(unknown), Li Lü, Nguyet M. Hoang, Fen Zhu, Paul D. Bates, Anusara Daenthanasanmak, Shanxiang Zhang, David T. Yang, (unknown), (unknown), Yangguang Li, (unknown), (unknown), (unknown), (unknown), Thomas A. Waldmann, Christian M. Capitini, Lixin Rui	10
3	Proapoptotic protein BIM as a novel prognostic marker in mantle cell lymphoma 2019 ·Human Pathology ·(unknown), Samuel G. Katz, Elizabeth A. Morgan, David T. Yang, Xueliang Pan, Mina L. Xu	9
4	PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cells 2019 ·Leukemia ·Fen Zhu, Hui Guo, Paul D. Bates, Shanxiang Zhang, Hui Zhang, Krystle Nomie, Yangguang Li, Li Lü, (unknown), Fangyu Wang, (unknown), (unknown), Nguyet M. Hoang, David T. Yang, Wei Xu, Liang Zhang, Michael Wang, Christian M. Capitini, Lixin Rui	54
5	Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen 2018 ·Clinical Lymphoma Myeloma & Leukemia ·Nirav N. Shah, Anikó Szabó, Raya Saba, Lauren E. Strelec, (unknown), John L. Vaughn, (unknown), David T. Yang, Anthony R. Mato, Abraham S. Kanate, Horatiu Olteanu, Mehdi Hamadani, Timothy S. Fenske, Vaishalee P. Kenkre, Jakub Svoboda, Amanda F. Cashen, Narendranath Epperla	9
6	Pegivirus avoids immune recognition but does not attenuate acute-phase disease in a macaque model of HIV infection 2017 ·PLoS Pathogens ·Adam L. Bailey, Connor R. Buechler, Daniel R. Matson, Eric Peterson, Kevin Brunner, Mariel S. Mohns, Meghan E. Breitbach, Laurel M. Stewart, Adam J. Ericsen, Christina M. Newman, Michelle R. Koenig, Emma L. Mohr, John Tan, Saverio Capuano, Heather A. Simmons, David T. Yang, David H. O’Connor	11
7	VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study 2017 ·Clinical Lymphoma Myeloma & Leukemia ·Elizabeth Chang, Lakeesha Carmichael, KyungMann Kim, Christopher G. Peterson, David T. Yang, Anne M. Traynor, Jae Werndli, (unknown), Thomas McFarland, Michael Volk, Jules H. Blank, Natalie S. Callander, Walter Longo, Brad S. Kahl	11
8	Retrograde Degeneration of Retinal Ganglion Cells Secondary to Head Trauma 2016 ·Optometry and Vision Science ·(unknown), (unknown), David T. Yang	29
9	FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma 2016 ·Oncogene ·Y Li, Myriam N. Bouchlaka, (unknown), Kreg Grindle, (unknown), Shuiming Qian, Xuehua Zhong, (unknown), (unknown), Brad S. Kahl, Jens C. Eickhoff, Shelly M. Wuerzberger‐Davis, Shigeki Miyamoto, Craig J. Thomas, David T. Yang, Christian M. Capitini, (unknown)	53
10	Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus 2015 ·Molecular Cancer Therapeutics ·Hung Huynh, Huai-Xiang Hao, Stephen L. Chan, David Chen, Richard Ong, Khee Chee Soo, Panisa Pochanard, David T. Yang, David A. Ruddy, Manway Liu, Adnan Derti, Marissa N. Balak, Michael R. Palmer, Yan Wang, Benjamin H. Lee, Dalila Sellami, Andrew X. Zhu, Robert Schlegel, Alan Huang	60
11	AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma 2015 ·Clinical Cancer Research ·Toni M. Brand, Mari Iida, Andrew P. Stein, Kelsey L. Corrigan, (unknown), John P. Coan, (unknown), Harsh Bahrar, (unknown), Bryan P. Bednarz, Sandeep Saha, David T. Yang, (unknown), Mark W. Lingen, Vassiliki Saloura, Victoria Villaflor, Ravi Salgia, Randall J. Kimple, Deric L. Wheeler	89
12	Phase 1 Trial of Bevacizumab With Concurrent Chemoradiation Therapy for Squamous Cell Carcinoma of the Head and Neck With Exploratory Functional Imaging of Tumor Hypoxia, Proliferation, and Perfusion 2015 ·International Journal of Radiation OncologyBiologyPhysics ·Matthew J. Nyflot, Tim J. Kruser, Anne M. Traynor, Deepak Khuntia, David T. Yang, Gregory K. Hartig, Timothy M. McCulloch, (unknown), Lindell R. Gentry, Tien Hoang, Robert Jeraj, Paul M. Harari	33
13	Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells 2015 ·Stem Cell Research ·Kran Suknuntha, Yuki Ishii, (unknown), Kejin Hu, Brian E. McIntosh, David T. Yang, Scott Swanson, Ron Stewart, Jean Y. J. Wang, James Thomson, Igor I. Slukvin	25
14	EXTENSIN18 is required for full male fertility as well as normal vegetative growth in Arabidopsis 2015 ·Frontiers in Plant Science ·Pratibha Choudhary, Prasenjit Saha, Tui Ray, Yuhong Tang, David T. Yang, Maura Cannon	22
15	Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer 2014 ·Molecular Cancer Therapeutics ·Toni M. Brand, Mari Iida, Emily Dunn, Neha Luthar, (unknown), Kelsey L. Corrigan, Matthew J. Wleklinski, David T. Yang, Kari B. Wisinski, Ravi Salgia, Deric L. Wheeler	40
16	Development and Characterization of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Tumorgrafts 2012 ·Clinical Cancer Research ·Randall J. Kimple, Paul M. Harari, Alexandra D. Torres, Robert Yang, (unknown), Menggang Yu, Eric A. Armstrong, Grace C. Blitzer, Molly A. Smith, Laurel D. Lorenz, Denis Lee, David T. Yang, Timothy M. McCulloch, Gregory K. Hartig, Paul F. Lambert	78
17	Extranodal NK/T-Cell Lymphoma Presenting with Primary Cardiac Involvement 2011 ·SHILAP Revista de lepidopterología ·(unknown), David T. Yang, Elizabeth Chang	14
18	Use of Tissue Microarray and Automated Quantitative Analysis for Screening and Validation of Potential Biomarkers in Mantle Cell Lymphoma 2010 ·Applied immunohistochemistry & molecular morphology ·David T. Yang, (unknown), Adam M. Petrich, Catherine P. Leith, Ken H. Young, Brad S. Kahl	6
19	Cytogenetics of a pediatric unclassified sex cord-stromal tumor of the testis: a case report 2004 ·Cancer Genetics and Cytogenetics ·David T. Yang, Amy Lowichik, Jige Chen, Brent W. Snow, Thomas M. Ulbright, (unknown)	1
20	Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect. 1995 ·Journal of Clinical Investigation ·Thomas A. Buchanan, (unknown), Young Y. Jeng, David T. Yang, T M Chan, Jerry L. Nadler, S. D. Scott, Robert K. Rude, Willa A. Hsueh	206

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact